Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 15, 2007 (Vol. 27, No. 16)

Ways to Arm Antibodies Under Increasing Scrutiny

Researchers Are Reviving the Concept of Immunoconjugate Antibodies

  • Recombinant antibodies have reached blockbuster drug status. Herceptin, Avastin, Remicade, and others rack up billions of dollars per year in sales. Almost all the clinically approved antibodies in use today are naked, or unconjugated, antibodies. When participants recently met for the Strategic Research Institute’s “World Antibody Summit,” discussion focused ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.